Similar Articles
341 Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
342 Cryptotanshinone induces apoptosis of activated hepatic stellate cells via modulating endoplasmic reticulum stress
343 Radiomic advances in the transarterial chemoembolization related therapy for hepatocellular carcinoma
344 Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges
345 Ablative strategies for recurrent hepatocellular carcinoma
346 Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
347 Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
348 Comprehensive analysis of prognostic value and immunotherapy prospect of brain cytoplasmic RNA1 in hepatocellular carcinoma
349 Correlation between immune-related adverse events and long-term outcomes in pembrolizumab-treated patients with unresectable hepatocellular carcinoma: A retrospective study
350 Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA